Yadav Pandey

ORCID: 0000-0003-2307-7310
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Cancer-related molecular mechanisms research
  • Molecular Biology Techniques and Applications
  • Multiple Myeloma Research and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Cervical Cancer and HPV Research
  • Lymphoma Diagnosis and Treatment
  • RNA modifications and cancer
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues
  • CAR-T cell therapy research
  • Cancer Treatment and Pharmacology
  • Circular RNAs in diseases
  • Ethics in medical practice
  • Hematological disorders and diagnostics
  • Pericarditis and Cardiac Tamponade
  • Case Reports on Hematomas
  • Complement system in diseases
  • CNS Lymphoma Diagnosis and Treatment
  • Chronic Kidney Disease and Diabetes
  • Immunodeficiency and Autoimmune Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Telemedicine and Telehealth Implementation
  • Ethnobotanical and Medicinal Plants Studies

University of Charleston
2024

University Medical Center
2024

Medical University of South Carolina
2023-2024

University of Arkansas for Medical Sciences
2018-2021

University of Arkansas Medical Center
2020

Winthrop Rockefeller Foundation
2020

Micro Labs (India)
2010

Bundelkhand University
2010

Holy Family Hospital
2000

Abstract Purpose: Human papillomavirus (HPV) is causally linked to oropharyngeal squamous cell carcinoma (OPSCC). Consensus guidelines recommend clinical exams and imaging in decreasing frequency as part of posttreatment surveillance for recurrence. Plasma tumor tissue modified viral (TTMV)-HPV DNA testing has emerged a biomarker which can inform disease status during surveillance. Experimental Design: This retrospective observational cohort study involved 543 patients who completed...

10.1158/1078-0432.ccr-23-1478 article EN cc-by-nc-nd Clinical Cancer Research 2023-08-11

Abstract Multiple myeloma (MM) patients frequently attain a bone marrow (BM) minimal residual disease (MRD) negativity status in response to treatment. We identified 568 who achieved BM MRD following autologous stem cell transplantation (ASCT) and maintenance combination therapy with an immunomodulatory agent proteasome inhibitor. was evaluated by next-generation flow cytometry (sensitivity of 10−5 cells) at 3- 6-month intervals. With median follow-up 9.9 years from diagnosis (range,...

10.1182/bloodadvances.2021005822 article EN cc-by-nc-nd Blood Advances 2021-11-22

Cardiac complications associated with influenza infection can occur either via a direct effect of the virus on heart or through exacerbation preexisting cardiovascular disease. We present case 57-year-old man acute complicated by pericardial effusion and cardiac tamponade.A white presented to Emergency Department sudden onset severe, nonexertional, retrosternal, pressure-like chest pain for few hours fever muscle aches 2 days. The patient was initially admitted because suspected coronary...

10.7812/tpp/18-104 article EN The Permanente Journal 2018-12-20

Older age is a melanoma risk factor. Elderly individuals are likelier to have immunosenescence, which could help cells escape immune surveillance. Hence, it believed that elderly people cannot mount potent response checkpoint inhibitors eliminate melanoma.To investigate age-related differences in the time progression, overall survival, and immunotherapy-related adverse events among patients with metastatic who received inhibitors.We retrospectively identified at our institution between...

10.7812/tpp/19.093 article EN The Permanente Journal 2020-02-14

Hemophagocytic lymphohistiocytosis (HLH) is an underrecognized disorder due to the variability of its presentation and fact that in adults, diagnosis based on cumbersome, pediatric-based criteria. Data regarding demographics, underlying causes, clinical features, laboratory results, complications, treatments received, outcomes were collected analyzed 41 patients who diagnosed treated at University Arkansas for Medical Sciences between 2007 2019. In this group, 51% male, median age was 47...

10.1080/08998280.2020.1740052 article EN Baylor University Medical Center Proceedings 2020-04-03

Acquired inhibitors of coagulation are a group rare but potentially life-threatening blood disorders characterized by the presence autoantibodies directed against clotting factor. Autoantibody factor VIII is most common form inhibitor, condition also known as acquired hemophilia A. We present clinical series nine patients diagnosed and treated for A at our institution. Among these patients, there were five men four women with median age 64 years. All presented bleeding diathesis. Factor...

10.1080/08998280.2019.1689024 article EN Baylor University Medical Center Proceedings 2019-11-20

Intravascular large B-cell lymphoma is a rare malignancy characterized by the presence of cells within lumen blood vessels. The annual incidence cases fewer than 0.5 per 1,000,000. It usually affects elderly with an average age diagnosis around 70 years. Due to absence in peripheral smear and lymphadenopathy, it difficult diagnose these cases. Although central nervous system skin are commonly involved organs, they can involve any organ system. Prompt initiation treatment very crucial as...

10.7759/cureus.16459 article EN Cureus 2021-07-18

<div>Abstract<p>Background: Human papillomavirus (HPV) is causally linked to oropharyngeal squamous cell carcinoma (OPSCC). Consensus guidelines recommend clinical exams and imaging in decreasing frequency as part of post-treatment surveillance for recurrence. Plasma tumor tissue modified viral (TTMV)-HPV DNA testing has emerged a biomarker which can inform disease status during surveillance. Methods: This retrospective observational cohort study involved 543 patients who...

10.1158/1078-0432.c.6879393.v2 preprint EN 2024-09-16

Abstract Purpose: Detecting minimal residual disease (MRD) has emerged as a key strategy in oncology for identifying those at high risk of relapse. Circulating tumor tissue modified viral (TTMV)-HPV DNA promising biomarker HPV-driven oropharyngeal cancer. Prior studies have largely focused on detection beyond three months post-treatment. This study evaluated the ability TTMV-HPV to detect MRD immediately after initial or salvage treatment. Patients and Methods: IRB-approved, retrospective...

10.1158/1557-3265.liqbiop24-b022 article EN Clinical Cancer Research 2024-11-13

Hemolytic uremic syndrome (HUS) is a type of thrombotic microangiopathy (TMA) defined as triad non-immune microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Shiga toxin (Stx) or diarrhea-associated HUS one the major categories secondary HUS, which seen predominantly in children regarded rare entity adult population. We present two cases sporadic Stx females. Our first case 74-year-old Caucasian woman who presented to emergency department with nausea, vomiting,...

10.7759/cureus.4435 article EN Cureus 2019-04-11

Patients with renal cell carcinoma (RCC) often remain asymptomatic until the disease is advanced, about 25% presenting at an advanced stage. We present a case of metastatic RCC treated combination ipilimumab and nivolumab complete radiological pathological response. Currently, preferred option for intermediate- poor-risk patients clear stage IV RCC.

10.1080/08998280.2020.1717264 article EN Baylor University Medical Center Proceedings 2020-01-30

Goel, Akshay1; Subramany, Swathi1; Wayne, Michelle1; Ibanez, Nicholas1; Pandey, Yadav1; Goraya, Harmeen1 Author Information

10.1097/01.ccm.0000551510.82195.c0 article Critical Care Medicine 2018-12-18

1 Background: Advance care planning (ACP), which includes advance directive (AD) completion, ensures that patients receive is consistent with their beliefs and preferences. ACP particularly important to cancer as they have high rates of hospitalization mortality. However, AD completion for oncology been reported be low 10%. We sought evaluate barriers improve in hospitalized our institution. Methods: 63 admitted inpatient unit were surveyed. A multi-disciplinary team, consisting resident...

10.1200/jco.2019.37.31_suppl.1 article EN Journal of Clinical Oncology 2019-11-01

8514 Background: Attainment of MRD negativity in multiple myeloma (MM) patients is increasingly considered an optimal therapeutic endpoint, but little known about the evolution those who achieve this milestone. We investigated clinical implication loss or conversion with ≥VGPR. Methods: identified and followed 606 achieving a sustained ≥VGPR bone marrow negativity(≥ 2 consecutive reading) following treatment on total therapy protocol median follow-up 10 y. All patient had negative PET MRI...

10.1200/jco.2020.38.15_suppl.8514 article EN Journal of Clinical Oncology 2020-05-20

Introduction: Hypercalcemia is relatively common in clinical practice. Primary hyperparathyroidism and malignancy accounts for more than 90 percent of all cases hypercalcemia. Milk alkali syndrome which hypercalcemia classically caused by ingestion large amount calcium absorbable was once virtually disappeared as a cause has emerged third leading We present case secondary to carbonate tablets resulting milk syndrome.Case presentation: Patient 45-year-old female with history gastroesophageal...

10.5430/crim.v5n2p31 article EN Case Reports in Internal Medicine 2018-05-16

Abstract Introduction: Indeterminate results of clinical or imaging examinations are common across the care continuum, and decisions made can lead to overtreatment psychological financial harms for patient. Additionally, due emergence highly sensitive circulating tumor DNA assays, an indeterminate status also arise when molecular detection precedes radiological evidence recurrence a period time. We recently reported >99% negative >95% positive predictive value tissue modified...

10.1158/1557-3265.aacrahns23-po-045 article EN Clinical Cancer Research 2023-09-15

<div>AbstractPurpose:<p>Human papillomavirus (HPV) is causally linked to oropharyngeal squamous cell carcinoma (OPSCC). Consensus guidelines recommend clinical exams and imaging in decreasing frequency as part of posttreatment surveillance for recurrence. Plasma tumor tissue modified viral (TTMV)-HPV DNA testing has emerged a biomarker which can inform disease status during surveillance.</p>Experimental Design:<p>This retrospective observational cohort study involved...

10.1158/1078-0432.c.6879393.v1 preprint EN 2023-10-13
Coming Soon ...